AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Treatment OutcomeOutcome Assessment (Health Care)Retrospective StudiesFollow-Up StudiesPregnancy OutcomePrognosisProspective StudiesTime FactorsAntitubercular AgentsCohort StudiesRisk FactorsOutcome and Process Assessment (Health Care)Severity of Illness IndexCognitive TherapyDirectly Observed TherapyPredictive Value of TestsTreatment FailureSurvival AnalysisReproducibility of ResultsRecurrenceCombined Modality TherapySurvival RatePatient ComplianceQuality of LifeTuberculosis, PulmonaryPregnancyRandomized Controlled Trials as TopicMultivariate AnalysisAge FactorsUnited StatesExtensively Drug-Resistant TuberculosisLogistic ModelsInfant, NewbornTuberculosis, Multidrug-ResistantSubstance-Related DisordersPatient SatisfactionHIV InfectionsRisk AssessmentBuprenorphineKaplan-Meier EstimateQuestionnairesPsychiatric Status Rating ScalesOpioid-Related DisordersPsychotherapyLongitudinal StudiesAlcoholismRegression AnalysisSubstance Abuse Treatment CentersDrug Therapy, CombinationAnalysis of VarianceTemperanceNeoplasm StagingPsychometricsTuberculosisHospitals, Chronic DiseaseCross-Sectional StudiesSex FactorsAntineoplastic Combined Chemotherapy ProtocolsResearch DesignIncidencePilot ProjectsPostoperative ComplicationsChi-Square DistributionDepressive Disorder, MajorClinical Trials as TopicCocaine-Related DisordersPatient DropoutsRemission InductionMagnetic Resonance ImagingPain MeasurementProportional Hazards ModelsGenotypeImplosive TherapyDouble-Blind MethodDisease ProgressionMethadoneDisability EvaluationSensitivity and SpecificityDisease-Free SurvivalStatistics, NonparametricMedication AdherenceRecovery of FunctionDepressionBiological MarkersChronic DiseasePrevalenceResidential TreatmentLinear ModelsBehavior TherapyRetreatmentPatient SelectionAnti-Retroviral AgentsMotivationHealth StatusAcute DiseaseCost-Benefit AnalysisSocioeconomic FactorsLength of StayAnti-HIV AgentsRegistries